Healthcare Triangle, Inc.

DB:4MR0 Stock Report

Market Cap: €16.9m

Healthcare Triangle Past Earnings Performance

Past criteria checks 0/6

Healthcare Triangle's earnings have been declining at an average annual rate of -85.2%, while the Healthcare Services industry saw earnings growing at 17.5% annually. Revenues have been growing at an average rate of 4.2% per year.

Key information

-85.2%

Earnings growth rate

-25.9%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate4.2%
Return on equity-152.3%
Net Margin-29.5%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Healthcare Triangle makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:4MR0 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2342-12125
31 Mar 2345-11135
31 Dec 2246-10126
30 Sep 2244-8135
30 Jun 2240-8125
31 Mar 2238-7106
31 Dec 2135-695
30 Sep 2135-174
30 Jun 2134262
31 Mar 2132162
31 Dec 2031252
31 Dec 1929121

Quality Earnings: 4MR0 is currently unprofitable.

Growing Profit Margin: 4MR0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4MR0 is unprofitable, and losses have increased over the past 5 years at a rate of 85.2% per year.

Accelerating Growth: Unable to compare 4MR0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4MR0 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.6%).


Return on Equity

High ROE: 4MR0 has a negative Return on Equity (-152.25%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.